FDA Label for Anticoagulant Citrate Dextrose A
View Indications, Usage & Precautions
- DESCRIPTION
- CLINICAL PHARMACOLOGY
- INDICATIONS AND USAGE
- CONTRAINDICATIONS
- WARNINGS
- GENERAL
- INFORMATION FOR PATIENTS
- CARCINOGENESIS, MUTAGENESIS, IMPAIRMENT OF FERTILITY
- PREGNANCY
- PEDIATRIC USE
- ADVERSE REACTIONS
- OVERDOSAGE
- DOSAGE AND ADMINISTRATION
- RX ONLY
- HOW SUPPLIED
- STORAGE AND HANDLING
- OTHER
- PRINCIPAL DISPLAY PANEL - 10 VIAL CASE LABEL
Anticoagulant Citrate Dextrose A Product Label
The following document was submitted to the FDA by the labeler of this product Citra Labs Llc. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Description
Anticoagulant Citrate Dextrose Solution, Solution A, U.S.P., (ACD-A), is a sterile, non-pyrogenic solution of citric acid, sodium citrate, and dextrose, in water for injection. Each 10 mL of solution contains:
Citric Acid, anhydrous, USP | 0.073 g |
Sodium Citrate, dihydrate, USP | 0.220 g |
Dextrose, monohydrate, USP | 0.245 g |
Water for Injection, USP | q.s. |
pH: 4.5 – 5.5 |
Clinical Pharmacology
ACD-A acts as an anticoagulant by the action of the citrate ion chelating free ionized calcium, thus making calcium unavailable to the coagulation system.
Indications And Usage
Anticoagulant Citrate Dextrose Solution, Solution A, U.S.P. (ACD-A), is intended for use as an anticoagulant in the extracorporeal blood processing with Autologous PRP Systems in production of platelet rich plasma (PRP). Refer to the manufacturer's Operator's Manual of the Autologous PRP System for the Directions for Use.
Contraindications
NOT FOR DIRECT INTRAVENOUS INFUSION
Warnings
NOT FOR DIRECT INTRAVENOUS INFUSION
General
- Aseptic technique must be maintained at all times.
- ACD-A solution is a clear and colorless solution. If the product shows any cloudiness or turbidity, the product should be discarded.
- The closure system provides a biological barrier and should be intact – discard product if system is compromised.
Information For Patients
None.
Carcinogenesis, Mutagenesis, Impairment Of Fertility
Long-term studies in animals have not been performed to evaluate the carcinogenic potential of ACD-A.
Pregnancy
Long-term studies in animals have not been performed to evaluate the effects of ACD- A on pregnant women.
Pediatric Use
The safety and effectiveness of ACD-A in children have not been established.
Adverse Reactions
Not applicable. This product is used as an anticoagulant in the extracorporeal blood processing with Autologous PRP Systems in production of platelet rich plasma (PRP).
Overdosage
Not applicable. This product is used as an anticoagulant in the extracorporeal blood processing with Autologous PRP systems in production of platelet rich plasma (PRP).
Dosage And Administration
Refer to the manufacturer's Operator's Manual of the Autologous PRP System for the Directions for Use.
Rx Only
Caution: Federal Law (US) restricts this devise to sale by or on the order of a Physician.
How Supplied
Anticoagulant Citrate Dextrose Solution, Solution A, U.S.P., (ACD-A)
REF | SIZE | CASE | |
---|---|---|---|
PN 9350-10 | 30 mL | 10 Vials/Case | |
PN 9350-25 | 30 mL | 25 Vials/Case |
Storage And Handling
It is recommended that the product be stored at ambient room temperature, 24 °C (75 °F); however, the product can be stored between 15 °C (59 °F) and 30 °C (86 °F). Protect from freezing and exposure to excessive heat should be minimized.
Other
Manufactured & Distributed by:
CitraLabs™
55 Messina Drive, Braintree, MA 02184
Phone Number: 1-800-299-3411
Authorized Representative:
Biomet U.K. Ltd.
Waterton Industrial Estate
Bridgend, South Wales, CF31 3XA
Great Britain
United Kingdom
Phone 441.65.66.55.221
Principal Display Panel - 10 Vial Case Label
C E 0044
ACD-A
Anticoagulant Citrate Dextrose Solution,
10 Vials / Case Solution A, U.S.P., ACD-A, 30 mL
REF PN 9350-10
WARNING: NOT FOR DIRECT INTRAVENOUS INFUSION
Used as an anticoagulant in the extracorporeal blood processing with
Autologous PRP Systems in production of platelet rich plasma (PRP).
Refer to PRP Systems manufacturer's Directions for Use.
Manufactured & Distributed by:
CitraLabs
A Biomet Biologics Company
Citra Labs, LLC.
55 Messina Drive, Braintree, MA 02184
1-800-299-3411
EC REP
Authorized Representative:
Biomet U.K. Ltd.,
Waterton Industrial Estate
Bridgend, South Wales, CF31 3XA
Great Britain - United Kingdom
Phone 441.65.66.55.221
STERILE • NON-PYROGENIC
Composition per 10 mL of Solution:
Citric Acid, (Anhydrous), U.S.P. 0.073 g.
Sodium Citrate, (Dihydrate), U.S.P. 0.220 g.
Dextrose, (Monohydrate), U.S.P. 0.245 g.
CAUTION: Single Procedure Use-Discard Unused Portion
Do Not Use Unless Solution is Clear and Seal is Intact.
Store Between 15 °C - 30 °C (59 °F - 86 °F).
RX Only:
EXP DATE
LOT
LA9350-10B 02/15
* Please review the disclaimer below.